A pharmacy benefits manager has gone ahead with a previously announced move to scoop up a competitor.
Express Scripts Inc., St. Louis, (Nasdaq:ESRX) has completed acquiring the NextRx PBM subsidiaries from WellPoint Inc., Indianapolis (NYSE:WLP).
Express Script is paying about $4.7 billion for the subsidiaries, “which includes consideration for the value of a future tax benefit for Express Scripts based on the structure of the transaction,” the companies say.